EUVIMEDEUVIMED entdecken
Kontrollierte klinische Studie

Immunogenicity and Safety of a 2 + 1 DTPa Priming Schedule in Australian Infants and the Impact of Maternally Derived Antibodies on Pertussis Antibody Responses up to 4 Years of Age

Sonia M McAlister, Alexandra Dierig, Anita H J van den Biggelaar, Ruth Thornton, Matthew N Cooper, Peter McIntyre, Peter C Richmond, Nicholas Wood

Journal of the Pediatric Infectious Diseases Society · 2025

DOI: 10.1093/jpids/piaf067 ↗

Kurz gefasst

Kontrollierte klinische Studie in der Zeitschrift Journal of the Pediatric Infectious Diseases Society, 2025. Verfasst von Sonia M McAlister und 7 weiteren Autor:innen. Beteiligte Einrichtung: Wesfarmers Centre of Vaccines & Infectious Disease, The Kids Research Institute Australia, Perth Children's Hospital, 15 Hospital Avenue, Nedlands, 6…. Hauptthemen laut MEDLINE: Antibodies, Bacterial, Diphtheria-Tetanus-acellular Pertussis Vaccines, Immunity, Maternally-Acquired, Immunization Schedule. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 12 Literaturangaben. Gefördert von: Foundation for Children.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

We assessed the impact of maternally derived pertussis antibodies on infant responses to a 2 + 1 vaccine schedule (6 weeks, 12 weeks, and 12 months). Infants with baseline antibodies showed lower IgG responses following the primary vaccination series, but this did not impair booster responses at 4 years of age. Clinical Trials: The study is registered on the Australian New Zealand Clinical Trials Registry – www.anzctr.org.au (Part 1: ACTRN12615000898550, Part 2: ACTRN12622001216707).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antibodies, BacterialDiphtheria-Tetanus-acellular Pertussis VaccinesImmunity, Maternally-AcquiredImmunization SchedulePertussis VaccineWhooping CoughChild, PreschoolFemaleHumansInfantMaleAustraliaBordetella pertussisImmunization, SecondaryImmunoglobulin G

Stichwörter der Autor:innen

immune interferenceimmunogenicityinfant immunizationpertussissafety

Substanzen

Antibodies, BacterialDiphtheria-Tetanus-acellular Pertussis VaccinesImmunoglobulin GPertussis Vaccine

Autor:innen und Institutionen

  • Wesfarmers Centre of Vaccines & Infectious Disease, The Kids Research Institute Australia, Perth Children's Hospital, 15 Hospital Avenue, Nedlands, 6009, WA, Australia.
  • School of Medicine, The University of Western Australia, Queen Elizabeth II Medical Centre, 17 Monash Avenue, Nedlands, 6009, WA, Australia.
  • National Centre for Immunisation Research and Surveillance, Westmead, NSW, Australia.
  • Centre for Child Health Research, The University of Western Australia, Perth, WA, Australia.
  • The Children's Hospital at Westmead, Westmead, NSW, Australia.
  • The University of Sydney, Sydney, NSW, Australia.

Förderung

  • Foundation for Children

Zitieren

APA

McAlister, S. M., Dierig, A., van den Biggelaar, A. H. J., Thornton, R., Cooper, M. N., McIntyre, P., Richmond, P. C., & Wood, N. (2025). Immunogenicity and Safety of a 2 + 1 DTPa Priming Schedule in Australian Infants and the Impact of Maternally Derived Antibodies on Pertussis Antibody Responses up to 4 Years of Age. Journal of the Pediatric Infectious Diseases Society. https://doi.org/10.1093/jpids/piaf067

Vancouver

McAlister SM, Dierig A, van den Biggelaar AHJ, Thornton R, Cooper MN, McIntyre P, et al. Immunogenicity and Safety of a 2 + 1 DTPa Priming Schedule in Australian Infants and the Impact of Maternally Derived Antibodies on Pertussis Antibody Responses up to 4 Years of Age. Journal of the Pediatric Infectious Diseases Society. 2025. doi:10.1093/jpids/piaf067

BibTeX
@article{McAlister2025,
  author = {McAlister, Sonia M and Dierig, Alexandra and van den Biggelaar, Anita H J and Thornton, Ruth and Cooper, Matthew N and McIntyre, Peter and Richmond, Peter C and Wood, Nicholas},
  title = {Immunogenicity and Safety of a 2 + 1 DTPa Priming Schedule in Australian Infants and the Impact of Maternally Derived Antibodies on Pertussis Antibody Responses up to 4 Years of Age},
  journal = {Journal of the Pediatric Infectious Diseases Society},
  year = {2025},
  doi = {10.1093/jpids/piaf067}
}
Kostenlos starten →